We use both our own and third-party cookies for statistical purposes and to improve our services. If you continue to browse, we consider that you accept the use of these.

Clinical Assays for Treatment Decisions

Our CAP/CLIA accredited laboratory is one of the only clinical laboratories specializing in RNA-based assays.

Leverage the dynamic nature of RNA,

Combined with our expertise in clinical samples.

Cofactor offers access to two clinically-validated assays to improve your clinical decision making abilities.

cap_cert_large_print_color

Our ImmunoPrism™ assay quantitatively measures 8 key immune cells in solid tumor samples from as little as two FFPE sections.

 

RNA-seqDx surveys the entire transcriptome to provide a broad look at a patient’s disease state.

 

Contact us to discuss how we can provide you with the insights you need.

CAP/CLIA-Grade RNA Sequencing Products

Product NameCatalog NumberDescriptionPrice per Sample
ImmunoPrism™ Clinical AssayCFGDx-301Clinically-validated immune characterization for solid tumorsContact Us
RNA-seqDxCFGDx-101CFGDx-102Fresh-Frozen CAP/CLIA RNA sequencing, 30 million single-end readsFresh-Frozen CAP/CLIA RNA sequencing, 60 million single-end reads$1000$1500

RNA-seqDx includes delivery of FASTQ files only and does not include comparative expression or other advanced analysis.

Learn more about our offerings.

Start typing and press Enter to search